Searchable abstracts of presentations at key conferences in endocrinology

ea0099ep876 | Reproductive and Developmental Endocrinology | ECE2024

Correlating adiposity with metabolic disturbances in PCOS patients: a single-centre retrospective study

Thadani Puja , Leca Bianca , Khan Uzma , Bate Danielle , Davasgaium Allan , Mattu Rajan , S. Randeva Harpal

Introduction: Polycystic Ovary Syndrome (PCOS) affects 5-10% of childbearing females and, up to 20% in specific ethnic populations (i.e. South Asians and Hispanics). It is linked with a higher prevalence of obesity and metabolic dysfunction, resulting in increased risk for dyslipidaemia, impaired glucose tolerance, type 2 diabetes mellitus (T2DM) and cardiovascular diseases.Methods: This is a retrospective study of patients diagnosed with PCOS (n</em...

ea0099ep734 | Adrenal and Cardiovascular Endocrinology | ECE2024

Hydrocortisone vs prednisolone for treatment of adrenal insufficiency disease (HYPER-AID Study) – interim results from a single, tertiary care centre

Maria Leca Bianca , Thadani Puja , Dineesha Kumarathunga Dineesha , Wellala Vindya , Davasgaium Allan , George Rojet , Seehra Parminder , Mattu Rajan , Randeva Harpal S.

Introduction: Adrenal insufficiency (AI) requires lifelong steroid replacement therapy, traditionally with hydrocortisone (HC), which, taken in divided doses, mimics the normal daytime cortisol profile. Prednisolone, with its longer duration of action, presents a cost-effective, once-daily alternative, yet its comparative efficacy and safety profile in AI management still need to be explored. Therefore, the current study aims to assess the metabolic and cardiovascular outcomes...